Skip to main content
SpringerLink
Log in

Pulmonale Erkrankungen

  • Chapter
Neugeborenenintensivpflege

  • 86 Accesses

Zusammenfassung

Die meisten pulmonalen Erkrankungen des Neugeborenen (s.auch S. 103) gehen mit Atemnot einher:

  • Tachypnoe über 60/min (Aufrechterhaltung eines normalen Atemzeitvolumens trotz hohen Atemwegwiderstands),

  • sternale Einziehungen (vermehrte Retraktionskraft der Lunge durch erhöhte Oberflächenspannung bei noch weichem Thoraxskelett),

  • exspiratorisches Stöhnen (verbesserter Gasaustausch durch Hinauszögern des alveolären Kollapses),

  • Nasenflügeln (Einsatz der auxiliären Atemmuskulatur).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman M, Wiggins JW (1985) Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75:80–87

    PubMed  CAS  Google Scholar 

  2. Ainsworth SB, Beresford MW, Milligan DW, Shaw NJ, Matthews JN, Fen-ton AC, Ward Piatt MP (2000) Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks’ gestation: a randomised trial. Lancet. 355:1387–1392

    PubMed  CAS  Google Scholar 

  3. Albersheim SG, Solimano AJ, Sharma AK, Smyth JA, Rothschild A, Wood BJ, Sheps SB (1989) Randomized, double-blind, controlled trial of long-term diuretic therapy for broncho-pulmonary dysplasia. J Pediatr 115: 615–620

    PubMed  CAS  Google Scholar 

  4. Arias Camison JM, Lau J, Cole CH, Frantz ID (1999) 3rd Meta analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 28:167–174

    PubMed  CAS  Google Scholar 

  5. Avery GB, Fletcher AB, Kaplan M, Brudno DS (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75:106–111

    PubMed  CAS  Google Scholar 

  6. Avery ME, Tooley WH, Keller JB et al. (1987) Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:16–30

    Google Scholar 

  7. Bancalari E, Abdenour GE, Feller R, Gannon J (1979) Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95:819–823

    PubMed  CAS  Google Scholar 

  8. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA (1999) Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181:709–717

    PubMed  CAS  Google Scholar 

  9. Barrington KJ, Finer NN (2000) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev CD000509

    Google Scholar 

  10. Baud O, Foix L’Helias L, Kaminski M et al. (1999) Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341:1190–1196

    PubMed  CAS  Google Scholar 

  11. Bent RC, Wiswell TE, Chang A (1992) Removing meconium from infant tracheae. What works best? Am J Dis Child 146:1085–1089

    PubMed  CAS  Google Scholar 

  12. Bertrand J, Riley SP, Popkin J et al. (1985) The long-term pulmonary sequelae of prematurity: the rate of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 312:742–745

    PubMed  CAS  Google Scholar 

  13. Bevilacqua G, Parmigiani S, Robertson B (1996) Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med 24:1–12

    Google Scholar 

  14. Bibi H, Seifert B, Oulette M, Belik J (1992) Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr Scand 81:335–339

    CAS  Google Scholar 

  15. Bloom BT, Kattwinkel J, Hall RT et al. (1997) Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 100:31–38

    PubMed  CAS  Google Scholar 

  16. Bose C, Wood M, Bose G, Donlon D, Friedman M (1990) Pulmonary function following positive pressure ventilation initiated immediately after birth in infants with respiratory distress syndrome. Pediatr Pulmonol 9:244–250

    PubMed  CAS  Google Scholar 

  17. Brion LP, Primhak RA (2000) Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001453

    Google Scholar 

  18. Brion LP, Primhak RA, Yong W (2000) Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001694

    Google Scholar 

  19. Brion LP, Primhak RA, Ambrosio Perez I (2000) Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev CD001817

    Google Scholar 

  20. Brown ER (1979) Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. Pediatr 95:865–866

    CAS  Google Scholar 

  21. Bührer C, Merker G, Falke KJ, Versmold H, Obladen M (1995) Dose response to inhaled nitric oxide in acute hypoxemic respiratory failure of newborn infants. Pediatr Pulmonol 19:291–298

    PubMed  Google Scholar 

  22. Chan V, Greenough A, Gamsu HR (1992) Neonatal complications of -extreme prematurity in mechanically ventilated infants. Eur J Pediatr I 151:693–696

    CAS  Google Scholar 

  23. Charafeddine L, D’Angio CT, Phelps DL (1999) Atypical chronic lung disease patterns in neonates. Pediatrics 103:759–765

    PubMed  CAS  Google Scholar 

  24. Christensen RD, Hunter DD, Goodell H, Rothstein G (1992) Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 120:593–598

    PubMed  CAS  Google Scholar 

  25. Clark DA, Pincus LG, Oliphant M et al (1982) HLA-A2 and chronic lung disease in neonates. JAMA 248:1868

    PubMed  CAS  Google Scholar 

  26. Cole CH, Colton T, Shah BL, Abbasi S, MacKinnon BL, Demissie S, Frantz ID 3rd (2000) Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia N Engl J Med 340:1005–1010

    Google Scholar 

  27. Collaborative Dexamethasone Trial Group (1991) Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88: 421–427

    Google Scholar 

  28. Darlow BA, Graham PJ (2000) Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev CD000501

    Google Scholar 

  29. Day RW, Lynch JM, White KS, Ward RM (1996) Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 98:698–705

    PubMed  CAS  Google Scholar 

  30. De Vito JM et al. (1983) Furosemide-associated ototoxicity. Clin Pharm 2:507–508

    Google Scholar 

  31. Doyle LW, Kitchen WH, Ford GW, Rickards AL, Lissendew JV, Ryan MM (1986) Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr 108:287–292

    PubMed  CAS  Google Scholar 

  32. Durand M, Sardesai S, McEvoy C (1995) Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial Pediatrics 95: 584–590

    PubMed  CAS  Google Scholar 

  33. Edwards DK, Colby TY, Northway WH (1979) Radiographic-pathologic correlation in bronchopulmonary dysplasia. J Pediatr 95:834–836

    PubMed  CAS  Google Scholar 

  34. Eronen M, Pohjavuori M, Andersson S, Pesonen E, Raivio KO (1997) Prostacyclin treatment for persistent pulmonary hypertension of the newborn. Pediatr Cardiol 18:3–7

    PubMed  CAS  Google Scholar 

  35. Evans N (1994) Cardiovascular effects of dexamethasone in the preterm infant. Arch Dis Child 70:F25-F30

    CAS  Google Scholar 

  36. Fanaroff AA, Hack M (1999) Periventricular leukomalacia prospects for prevention. N Engl J Med 14 341:1229–1231

    Google Scholar 

  37. Flenady VJ, Gray PH (2000) Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. Cochrane Database Syst Rev CD000283

    Google Scholar 

  38. Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1:55–59

    PubMed  CAS  Google Scholar 

  39. Giedion A, Haeflinger H, Dangel P (1973) Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive endexpiratory pressure. Pediatric Radiol 1:145

    CAS  Google Scholar 

  40. Hack H, Hörbar JD, Malloy MH, Tyson JE, Wright E, Wright L (1991) Very low birth weight outcomes of the National Institute of Child Health and human development neonatal network. Pediatrics 87:587–597

    PubMed  CAS  Google Scholar 

  41. Halliday HL (1995) Overview of clinical trials comparing natural and synthetic surfactants. Biol Neonate 67 (Suppl l):32–47

    PubMed  Google Scholar 

  42. Halliday HL (1996) Natural vs. synthetic surfactants in neonatal respiratory distress syndrome. Drugs 51:226–237

    PubMed  CAS  Google Scholar 

  43. Halliday HL (2000) Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. Cochrane Database Syst Rev CD000500

    Google Scholar 

  44. Halliday HL, Ehrenkranz RA (2000) Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001145

    Google Scholar 

  45. Halliday HL, Ehrenkranz RA (2000) Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev CD001146

    Google Scholar 

  46. Halliday HL, Tarnow-Mordi WO, Corcoran JD, Patterson CC (1993) Multicentre randomised trial comparing high and low dose surfactant regimes for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 69:276–280

    PubMed  CAS  Google Scholar 

  47. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M (1992) Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 326:1233–1239

    PubMed  CAS  Google Scholar 

  48. Hammerman C, Aramburo MJ (1988) Decreased lipid intake reduces morbidity in sick premature neonates. J Pediatr 113:1083–1088

    PubMed  CAS  Google Scholar 

  49. Harding JE, Miles FK, Becroft DM, Allen BC, Knight DB (1998) Chest physiotherapy may be associated with brain damage in extremely premature infants. J Pediatr 132:440–444

    PubMed  CAS  Google Scholar 

  50. Hartnoll G, Betremieux P, Modi N (2000) Randomised controlled trial of postnatal sodium supplementation on body composition in 25 to 30 week gestational age infants. Arch Dis Child 82:F24-F28

    CAS  Google Scholar 

  51. Hellström-Westas L, Bell AH, Skov L, Greisen G, Svenningsen NW (1992) Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics 89:643–647

    PubMed  Google Scholar 

  52. Hill A, Perlman JM, Volpe J J (1982) Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics 69:144–149

    PubMed  CAS  Google Scholar 

  53. Hjalmarson O (1981) Epidemiology and classification of acute neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70: 773–783

    PubMed  CAS  Google Scholar 

  54. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD (1997) Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25:352–359

    PubMed  CAS  Google Scholar 

  55. Howlett A, Ohlsson A (2000) Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev CD000366

    Google Scholar 

  56. Hufnagle KG, Khan SN, Penn D et al. (1982) Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 70:360–363

    PubMed  CAS  Google Scholar 

  57. Izraeli S, Samra Z, Sirota L, Merlob P, Davidson (1991) Genital mycoplasmas in preterm infants: prevalence and clinical significance. Eur J Pediatr 150:804–807

    PubMed  CAS  Google Scholar 

  58. Jobe AH (2000) Which surfactant for treatment of respiratory-distress syndrome. Lancet 355:1380–1381

    PubMed  CAS  Google Scholar 

  59. Jobe AJ (1999) The new BPD: an arrest of lung development. Pediatr Res 46:641–643

    PubMed  CAS  Google Scholar 

  60. Kao LC, Warburton D, Cheng MH, Cedeno C, Platzker ACG, Keens TG (1984) Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics 74:37–44

    PubMed  CAS  Google Scholar 

  61. Kattner E, Metze B, Waiß E, Obladen M (1992) Accelerated lung maturation following maternal steroid treatment in infants born before 30 weeks gestation. Perinat Med 20:449–457

    CAS  Google Scholar 

  62. Kendig JW, Notter RH, Cox C et al. (1991) A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. N Engl J Med 324:865–871

    PubMed  CAS  Google Scholar 

  63. Kinsella JP, Truog WE, Walsh WF et al. (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131:55–62

    PubMed  CAS  Google Scholar 

  64. Kukkonen AK, Virtanen M, Järvenpää AL, Pokela ML, Ikonen S, Fellmann V (2000) Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Padiatr 89:556–561

    CAS  Google Scholar 

  65. Kwong MS, Egan EA (1986) Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mothers with premature labor: use of Ritodrine and Betamethasone. Pediatrics 78:767–774

    PubMed  CAS  Google Scholar 

  66. Mammel MC, Green TP, Johnson DE, Thompson TR (1983) Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1:1356–1358

    PubMed  CAS  Google Scholar 

  67. Markowitz RI, Mercurio MR, Vahjen GA, Gross I, Touloukian RJ (1989) Congenital lobar emphysema: The role of CT and V/Q scan. Clin Pediatr 28:19–23

    CAS  Google Scholar 

  68. McCoy KS, Bagwell E, Wagner M, Salient J, O’Keefe M, Kosch PC (1992) Spirometric and endoscopic evaluation of airway collapse in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 14:23–27

    PubMed  CAS  Google Scholar 

  69. Meiseis SJ, Plunkett JW, Roloff DW, Pasick PL, Stiefel GS (1986) Growth and development of preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. Pediatrics 77:345–352

    Google Scholar 

  70. Merritt TA, Hallman M, Berry C et al. (1991) Randomized, placebo-controlled trial of human surfactant given at birth vs. rescue administration in very-low-birthweight infants with lung immaturity. Pediatrics 118: 581–594

    CAS  Google Scholar 

  71. Meyer E, Obladen M (1986) Unbeabsichtigte Pericardpunktion mit einem Mathys-Katheter. Pädiatr Prax 33:121–123

    Google Scholar 

  72. Milner AD (1994) Nitric oxide. Eur J Pediatr 153:7–11

    Google Scholar 

  73. Monin P, Vert P (1987) The management of bronchopulmonary dysplasia. Clin Perinatol 14:531–549

    PubMed  CAS  Google Scholar 

  74. Ng PC, Brownlee KG, Dear PRF (1991) Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. Arch Dis Child 66:1164–1166

    PubMed  CAS  Google Scholar 

  75. Nishibayashi SW, Andrassy RJ, Wolley MM (1981) Congenital cystic adenomatoid malformation: a 30 year experience. J Pediatr Surg 16: 704–706

    PubMed  CAS  Google Scholar 

  76. Northway WH, Moss RB, Carlisle et al. (1990) Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 323:1793–1799

    PubMed  Google Scholar 

  77. Northway WH, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 276:357–368

    PubMed  Google Scholar 

  78. Obladen M, Maier RF (1993) Respiratory disorders of the neonate. Current Opinion in Pediatrics 5:156–161

    PubMed  CAS  Google Scholar 

  79. Ollikainen J, Hiekkaniemi H, Korppi M, Sarkkinen H, Heinonen K (1993) Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infants. J Pediatr 122:756–760

    PubMed  CAS  Google Scholar 

  80. O’Neil EA, Chwals WJ, O’Shea MD, Turner CS (1991) Dexamethasone treatment during ventilator dependency: possiblel life threatening gastrointestinal complication. Arch Dis Child 67:10–11

    Google Scholar 

  81. OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insuffiency — the role of surfactant) (1991) Early vs. delayed neonatal administration of a synthetic surfactant — the judgement of OSIRIS. Lancet 340:1363–1369

    Google Scholar 

  82. Papile LA, Tyson JE, Stoll BJ et al. (1998) Multicenter trial of two dexamethasone regimens in ventilator dependent premature infants. N Engl J Med 338:1112–1118

    PubMed  CAS  Google Scholar 

  83. Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM (1998) Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1 beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 17:321–328

    PubMed  CAS  Google Scholar 

  84. Pearson E, Bose C, Snidow T, Ransom L, Young T, Bose G, Stiles A (1992) Trial of vitamin A supplementation in very low birthweight infants at risk for bronchopulmonary dysplasia. J Pediatr 121:420–427

    PubMed  CAS  Google Scholar 

  85. Perelman RH, Palta M, Kirby R, Farrell PM (1986) Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 78:238–244

    PubMed  CAS  Google Scholar 

  86. Raju TN, Langenberg P (1993) Pulmonary hemorrhage and exogenous surfactant therapy: A metaanalysis. Pediatrics 123:603–610

    CAS  Google Scholar 

  87. Rey M, Bührer C, Obladen M (1992) (Dick-)Grünes Fruchtwasser und das Mekoniumaspirationssyndrom. Anmerkungen zur Pathophysiologie und zum Management. Perinat Med 4:17–20

    Google Scholar 

  88. Roberts JD Jr, Fineman JR, Morin FC 3rd et al. (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336:605–10

    PubMed  CAS  Google Scholar 

  89. Segerer H, Stevens P, Schadow B et al. (1991) Surfactant substitution in ventilated very-low-birthweight infants: Factors related to response types. Pediatr Res 30:591–596

    PubMed  CAS  Google Scholar 

  90. Shenai JP (1999) Vitamin A supplementation in very low birth weight neonates: rationale and evidence. Pediatrics 104:1369–1374

    PubMed  CAS  Google Scholar 

  91. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 82:527–532

    PubMed  CAS  Google Scholar 

  92. Shinwell ES, Karplus M, Zmora E (1999) Early postnatal dexamethasone therapy is associated with increased risk for cerebral palsy. 14th International Workshop on Surfactant Replacement, Skagen 23.–25.6.1999

    Google Scholar 

  93. Sinkin RA, Cox C, Phelps DL (1990) Predicting risk for bronchopulmonary dysplasia: Selection criteria for clinical trials. Pediatrics 86:728–736

    PubMed  CAS  Google Scholar 

  94. Soll RF (2000) Multiple vs. single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst RevCDOOOHl

    Google Scholar 

  95. Soll RF (2000) Natural surfactant extract vs. synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD000144

    Google Scholar 

  96. Soil RF (2000) Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000511

    Google Scholar 

  97. Soil RF, Dargaville P (2000) Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev CD002054

    Google Scholar 

  98. Soil RF, Morley CJ (2000) Prophylactic vs. selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000510

    Google Scholar 

  99. Speer CP, Robertson B, Curstedt T et al. (1992) Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: Single vs. multiple doses of Curosurf. Pediatrics 89:13–20

    PubMed  CAS  Google Scholar 

  100. Speer CH, Robertson B, Halliday HL (2000) Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 89:510–512

    PubMed  CAS  Google Scholar 

  101. Teaque WG, Heldt GP, Tooley WH (1986) Hypoxia causes bronchocon-striction in infants with chronic lung disease. Pediatric Res 20:443

    Google Scholar 

  102. Toce SS, Farell PM, Leavitt LA, Samuels DP, Edwards DK (1984) Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 138:581–585

    PubMed  CAS  Google Scholar 

  103. Tyson JE, Wright LL, Oh W et al. (1999) Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340:1962–1968

    PubMed  CAS  Google Scholar 

  104. Van Marter L, Pagano M, Allred EN, Leviton A, Kuban KCK (1992) Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 120:938–946

    PubMed  Google Scholar 

  105. Waites KB, Crouse DT, Cassell GH (1992) Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 11:23–29

    PubMed  CAS  Google Scholar 

  106. Watts JL, Milner R, Zipurski A et al. (1991) Failure of supplementation with Vitamin E to prevent bronchopulmonary dysplasia in infants ≤ 1500 g birth weight. Eur Respir J 4:188–190

    PubMed  CAS  Google Scholar 

  107. Wauer RR, Schmalisch G, Bohme B, Arand J, Lehmann D (1992) Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome. Eur J Pediatr 151:357–363

    PubMed  CAS  Google Scholar 

  108. Werner JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary disease. J Pediatr 120:286–291

    PubMed  CAS  Google Scholar 

  109. Wilkie RA, Bryan MH (1987) Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr 111:278–282

    PubMed  CAS  Google Scholar 

  110. Wiswell TE, Tuggle JM, Turner BS (1990) Meconium aspiration syndrome: Have we made a difference? Pediatrics 85:715–721

    PubMed  CAS  Google Scholar 

  111. Wood B, Dubik M (1995) A new device for pleural drainage in newborn infants. Pediatrics 96:955–956

    PubMed  CAS  Google Scholar 

  112. Yeh TF, Lin YJ, Huang CC et al. (1998) Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101:E7

    PubMed  CAS  Google Scholar 

  113. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI (1997) Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177:825–830

    PubMed  CAS  Google Scholar 

  114. Yost CC, Soll RF (2000) Early vs. delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD001456

    Google Scholar 

  115. Yiiksel B, Greenough A, Karani J (1993) Prediction of chronic lung disease from the chest radiograph appearance at seven days of age. Acta Paediatr 82:944–947

    Google Scholar 

Download references

Authors
  1. M. Obladen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Kinderkardiologie, Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Georg Bein (ehem. Direktor) (ehem. Direktor)

  2. Klinik für Neonatologie, Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Rolf F. Maier (leitender Oberarzt) (leitender Oberarzt)

  3. Abteilung für Kinderchirurgie, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Deutschland

    Jürgen Waldschmidt (ehem. Leiter) (ehem. Leiter)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Obladen, M. (2002). Pulmonale Erkrankungen. In: Bein, G., Maier, R.F., Waldschmidt, J. (eds) Neugeborenenintensivpflege. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08937-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08937-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-41360-8

  • Online ISBN: 978-3-662-08937-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation